FDA device listing

EliA™ ANCA/GBM Positive Control 250,EliA™ GBM Immunoassay,EliA™ MPOS Immunoassay,EliA™ PR3S Immunoassay

FDA device listing 1163394633 · PHADIA AB

Key facts

Proprietary names EliA™ ANCA/GBM Positive Control 250,EliA™ GBM Immunoassay,EliA™ MPOS Immunoassay,EliA™ PR3S Immunoassay
Owner/operator PHADIA AB
Owner/operator number 9004441
Premarket submissions K140225
Product codes JJY, MOB, MVJ
Device names JJY - Multi-Analyte Controls, All Kinds (Assayed), MOB - Test System, Antineutrophil Cytoplasmic Antibodies (Anca), MVJ - Devices, Measure, Antibodies To Glomerular Basement Membrane (Gbm)
Device class Class I, Class II
Classification regulations (21 CFR) 862.1660, 866.5660
Review panels Clinical Chemistry, Immunology
Registered establishments PHADIA AB, PHADIA US INC.
Establishment registrations 9610566, 3004973408, 3039353646
FEI numbers 3002807876, 3004973408, 3039353646
Establishment operations Complaint File Establishment, Manufacturer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings